CAT-8015: A Second-generation Pseudomonas Exotoxin A-Based Immunotherapy Targeting CD22 -Expressing Hematological Malignancies

Por Alderson, Ralph F., Kreitman, Robert J., Chen, Tianling, Yeung, Peter, Herbst, Ronald, Fox, Judy A., Pastan, Ira
Publicado em 2009

Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma

Por Tong, Wei-Gang, Chen, Rong, Plunkett, William, Siegel, David, Sinha, Rajni, Harvey, R. Donald, Badros, Ashraf Z., Popplewell, Leslie, Coutre, Steven, Fox, Judith A., Mahadocon, Kristi, Chen, Tianling, Kegley, Peggy, Hoch, Ute, Wierda, William G.
Publicado no J Clin Oncol (2010)

A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia

Por Lancet, Jeffrey E., Roboz, Gail J., Cripe, Larry D., Michelson, Glenn C., Fox, Judith A., Leavitt, Richard D., Chen, Tianling, Hawtin, Rachael, Craig, Adam R., Ravandi, Farhad, Maris, Michael B., Stuart, Robert K., Karp, Judith E.
Publicado no Haematologica (2015)